Table 2. Complete-case efficacy analysis.

	20 mg/kg/day PM for 21 days (N = 21)	15 mg/kg/day PM for 28 days (N = 21)
End of treatment	18/21 (85.7%)95% CI: 63.7–97.0%	19/21 (90.5%)95% CI: 69.6–98.8%
6-month follow-up *	16/20 (80.0%)95% CI: 56.3–94.3%	17/21 (81.0%)95% CI: 58.1–94.6%

Data are n (%). CI, confidence interval.

*One patient lost to follow-up at 6 months in the 20 mg/kg group: worst-case efficacy = 16/21 (76.2%, 95% CI: 52.8–91.8%).